SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: (8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one-11,11,12,12-d4
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: C[C@@]1([C@H]2C(CO)=O)[C@](CC2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(CC4)C)([H])C([2H])([2H])C1([2H])[2H]
21-Hydroxyprogesterone D4 is chemically (8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one-11,11,12,12-d4. 21-Hydroxyprogesterone D4 is supplied with detailed characterization data compliant with regulatory guideline. 21-Hydroxyprogesterone D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Progesterone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Column selection approach for related substances determination of progesterone by high‐performance liquid chromatography
Ying Huang Hui Xiao Yaxiong Liu Jiaming Gan Quanhong Yan
chemical biology and drug design Volume93, Issue1 January 2019 Pages 29-37
Characterization of Progesterone Derivatives by LC-DAD-ESI/MSn and Its Application to the Identification of Impurities in Flurogestone Acetate
Yufeng Zhang, Zunyuan Wang, Zhen Ma & Yiyu Cheng
Chromatographia volume 68, pages903–909(2008)
Fifty-year old samples of progesterone demonstrate the complex role of synthetic impurities in stabilizing a metastable polymorph
Robert W. Lancaster, Lisa D. Harris and David Pearson
CrystEngComm, 2011,13, 1775-1777
Analytical Method Development and Validation for the Estimation of Abiraterone and its Impurity in Pharmaceutical Formulation By RP-HPLC
Kuna AK * , Seru Ganapaty and Gadela V Radha
Der Pharmacia Lettre, 2018, 10 [9]: 19-31